Skip to main content
LivaNova PLC logo

LivaNova PLC — Investor Relations & Filings

Ticker · LIVN ISIN · GB00BYMT0J19 LEI · 2138001K2FX6SHK2B339 US Manufacturing
Filings indexed 943 across all filing types
Latest filing 2017-03-01 Regulatory Filings
Country GB United Kingdom
Listing US LIVN

About LivaNova PLC

https://www.livanova.com/

LivaNova PLC is a global medical technology company that designs, develops, and manufactures devices and therapies focused on neurological and cardiac conditions. The company operates through two primary business segments: Neuromodulation and Cardiopulmonary. The Neuromodulation portfolio features Vagus Nerve Stimulation (VNS) Therapy™, a treatment for drug-resistant epilepsy and difficult-to-treat depression. The Cardiopulmonary segment provides a comprehensive suite of products essential for open-heart surgery, including heart-lung machines, such as the Essenz™ Perfusion System, oxygenators, and autotransfusion systems. LivaNova is dedicated to creating innovative medical solutions to address significant unmet patient needs and improve health outcomes.

Recent filings

Filing Released Lang Actions
LIVANOVA PLC - PRODUCT REMEDIATION PLAN RELATED TO 3T HEATER COOLER DEVICE.
Regulatory Filings
2017-03-01 English
Form 10-K
Annual Report Classification · 100% confidence The document is explicitly titled 'Form 10-K' and includes standard SEC regulatory headers, such as 'UNITED STATES SECURITIES AND EXCHANGE COMMISSION'. It covers the fiscal year ended December 31, 2016, and contains a comprehensive table of contents detailing business operations, risk factors, and financial statements. This matches the definition of an Annual Report (10-K). FY 2016
2017-03-01 English
LivaNova PLC Form 8-K - Product remediation plan re 3T Heater Cooler device
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC. Form 8-K is a 'current report' used to announce major events that shareholders should know about. In this specific instance, the company is disclosing a product remediation plan and associated financial liabilities. Since Form 8-K is a general regulatory filing used for various material events that do not fit into more specific categories like 'Earnings Release' or 'M&A', it is best classified under the 'Regulatory Filings' (RNS) category.
2017-03-01 English
LIVANOVA FORM 8-K RE CEO COMPENSATION & ANNUAL BONUS PLAN
Regulatory Filings
2017-02-28 English
LivaNova Form 8-K Bonus Plan and McDonald Compensation
Regulatory Filings Classification · 95% confidence The document is a US SEC Form 8-K filing. Item 5.02 specifically addresses the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers'. It details the CEO's employment agreement, salary, and incentive plans. While it contains management information, SEC Form 8-K filings that do not fit into other specific categories are classified as Regulatory Filings (RNS) in this schema, as they serve as the standard vehicle for miscellaneous material event disclosures.
2017-02-28 English
LivaNova Form 8-K re CEO Compensation and Short-Term Bonus Plan
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the U.S. Securities and Exchange Commission by LivaNova PLC. It details the departure/appointment of a CEO, the approval of a short-term incentive plan, and the filing of employment agreements as exhibits. While it contains remuneration details, the primary purpose of an 8-K is to report material corporate events (management changes and compensatory arrangements). According to the provided filing definitions, this fits the 'Board/Management Information' (MANG) category as it specifically addresses the appointment of a CEO and executive compensation arrangements.
2017-02-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.